10x Genomics, Inc.
TXG
$22.37
-$0.25-1.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 523.41M | 482.08M | 447.26M | 426.91M | 393.40M |
| Total Receivables | 82.49M | 96.59M | 119.07M | 52.55M | 88.47M |
| Inventory | 56.34M | 61.96M | 68.97M | 74.71M | 83.11M |
| Prepaid Expenses | 22.21M | 19.20M | 20.37M | 25.57M | 19.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 684.45M | 659.83M | 655.66M | 579.73M | 584.39M |
|
|
|||||
| Total Current Assets | 684.45M | 659.83M | 655.66M | 579.73M | 584.39M |
| Net Property, Plant & Equipment | 287.16M | 296.18M | 302.41M | 301.66M | 309.94M |
| Long-term Investments | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
| Goodwill | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
| Total Other Intangibles | 62.33M | 64.76M | 14.71M | 15.19M | 15.67M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.91M | 2.08M | 2.67M | 2.30M | 4.13M |
| Total Assets | 1.04B | 1.03B | 979.97M | 903.39M | 918.64M |
|
|
|||||
| Total Accounts Payable | 12.73M | 18.07M | 15.94M | 10.07M | 12.91M |
| Total Accrued Expenses | 51.89M | 48.19M | 38.92M | 40.91M | 52.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.99M | 10.54M | 9.67M | 9.44M | 9.29M |
| Total Finance Division Other Current Liabilities | 77.85M | 70.53M | 47.70M | 47.48M | 43.37M |
| Total Other Current Liabilities | 77.85M | 70.53M | 47.70M | 47.48M | 43.37M |
| Total Current Liabilities | 153.45M | 147.32M | 112.22M | 107.90M | 117.63M |
|
|
|||||
| Total Current Liabilities | 153.45M | 147.32M | 112.22M | 107.90M | 117.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 73.38M | 76.44M | 77.08M | 70.63M | 73.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.21M | 18.48M | 17.40M | 17.97M | 17.54M |
| Total Liabilities | 245.04M | 242.24M | 206.69M | 196.50M | 208.50M |
|
|
|||||
| Common Stock & APIC | 2.31B | 2.28B | 2.24B | 2.21B | 2.18B |
| Retained Earnings | -1.51B | -1.49B | -1.47B | -1.50B | -1.47B |
| Treasury Stock & Other | 225.00K | 138.00K | 220.00K | -367.00K | -493.00K |
| Total Common Equity | 796.33M | 785.12M | 773.28M | 706.90M | 710.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 796.33M | 785.12M | 773.28M | 706.90M | 710.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 796.33M | 785.12M | 773.28M | 706.90M | 710.13M |
|
|
|||||